The last several weeks have seen several dramatic mergers of drug companies. Two experts talk about what these changes will mean for the industry, for stockholders, for drug research, and for consumers.


  • Dr. Sidney Wolfe Director of the Health Research Group at Public Citizen; editor of
  • Wayne Pines Consultant to the pharmaceutical industry

Related Links

Topics + Tags


comments powered by Disqus
Most Recent Shows